DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,841 | +12.9% | 23,541 | +9.2% | 0.11% | +4.8% |
| Q2 2023 | $5,172 | -4.8% | 21,548 | 0.0% | 0.10% | -10.3% |
| Q1 2023 | $5,431 | -5.0% | 21,548 | 0.0% | 0.12% | -9.4% |
| Q4 2022 | $5,719 | -99.9% | 21,548 | 0.0% | 0.13% | -6.6% |
| Q3 2022 | $5,566,000 | +1.9% | 21,548 | 0.0% | 0.14% | +7.0% |
| Q2 2022 | $5,463,000 | +45.6% | 21,548 | +68.5% | 0.13% | +15.3% |
| Q1 2022 | $3,752,000 | -10.8% | 12,791 | 0.0% | 0.11% | -5.9% |
| Q4 2021 | $4,208,000 | +33.0% | 12,791 | +23.1% | 0.12% | +1.7% |
| Q3 2021 | $3,163,000 | +13.5% | 10,390 | 0.0% | 0.12% | +2.7% |
| Q2 2021 | $2,788,000 | +19.2% | 10,390 | 0.0% | 0.11% | +9.7% |
| Q1 2021 | $2,339,000 | +1.3% | 10,390 | 0.0% | 0.10% | -4.6% |
| Q4 2020 | $2,308,000 | +101.0% | 10,390 | +94.9% | 0.11% | -28.9% |
| Q3 2020 | $1,148,000 | -11.4% | 5,331 | -43.0% | 0.15% | -76.4% |
| Q1 2020 | $1,295,000 | +13.9% | 9,354 | +26.3% | 0.64% | +48.7% |
| Q4 2019 | $1,137,000 | – | 7,407 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |